{
  "actions": [
    {
      "acted_at": "2017-05-19", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2017-05-19", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2017-05-26", 
      "action_code": "", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr2562-115", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "115", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2017-05-19", 
  "number": "2562", 
  "official_title": "To improve access to prescription drugs.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "s934-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "s1115-115", 
      "identified_by": "CRS", 
      "reason": "identical", 
      "type": "bill"
    }
  ], 
  "short_title": "Making Pharmaceutical Markets More Competitive Act", 
  "sponsor": {
    "bioguide_id": "K000376", 
    "district": "3", 
    "name": "Kelly, Mike", 
    "state": "PA", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2017-05-19", 
  "subjects": [
    "Administrative remedies", 
    "Congressional oversight", 
    "Department of Health and Human Services", 
    "Drug safety, medical device, and laboratory regulation", 
    "Government information and archives", 
    "Health", 
    "Prescription drugs"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2017-05-19T04:00:00Z", 
    "text": "Making Pharmaceutical Markets More Competitive Act\n\nThis bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to\u00a0prioritize the review of generic drug applications and supplements\u00a0with respect to\u00a0drugs that are in a shortage or for which there are not more than three approved drugs.\n\nThe holder of an approved drug application must notify the FDA within 180 days of withdrawing or transferring the application or withdrawing the drug from sale.\n\nThe FDA must maintain a list of generic drugs with three or fewer holders of approved applications."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To improve access to prescription drugs.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Making Pharmaceutical Markets More Competitive Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Making Pharmaceutical Markets More Competitive Act", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Making Pharmaceutical Markets More Competitive Act", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-04-18T16:09:09Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/115/hr/BILLSTATUS-115hr2562.xml"
}